Biotech Values

[iwfal]

I have not said that a CU program is in fact coming; rather, I’ve said that DNDN longs have been intellectually dishonest in the way they have dismissed the possibility.

Is there some precedent for this? Do you have an example of a drug that was given an approvable and immediately instituted a CU program. I asked someone else espousing this view and he gave an example of Revlimid - but Revlimid was actually fully approved. They opened a CU program for a completely different indication.

Clark